Technical Analysis for OBIO - Orchestra BioMed Holdings, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 0.00% | |
| New Downtrend | Bearish | 0.00% | |
| Slingshot Bullish | Bullish Swing Setup | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | -12.64% | |
| Volume Surge | Other | -12.64% | |
| Doji - Bearish? | Reversal | -12.64% | |
| Wide Bands | Range Expansion | -12.64% | |
| Up 3 Days in a Row | Strength | -12.64% | |
| Crossed Above 20 DMA | Bullish | -10.21% |
| Alert | Time |
|---|---|
| Down 5% | about 7 hours ago |
| Down 3% | about 7 hours ago |
| Fell Below Previous Day's Low | about 7 hours ago |
| Down 2 % | about 7 hours ago |
| Down 1% | about 7 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Orchestra BioMed, Inc. operates as a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. It offers BackBeat Cardiac Neuromodulation Therapy (CNT), a patented, intelligent bioelectronic treatment for hypertension; Virtue SAB, a patented drug/device combination product for the treatment of artery disease; FreeHold Retractors, a minimally invasive surgical device solution; and Virtue SEB, a drug-eluting balloon angioplasty system for the treatment of coronary artery disease. Orchestra BioMed, Inc. has a strategic collaboration with Medtronic to develop BackBeat CNT as a potential treatment for hypertension in patients who are indicated for a cardiac pacemaker. The company was incorporated in 2017 and is based in New Hope, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Hypertension Cardiovascular Disease Neuromodulation Artery Disease Coronary Artery Disease Angioplasty Medtronic
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Hypertension Cardiovascular Disease Neuromodulation Artery Disease Coronary Artery Disease Angioplasty Medtronic
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.68 |
| 52 Week Low | 4.22 |
| Average Volume | 97,860 |
| 200-Day Moving Average | 6.58 |
| 50-Day Moving Average | 6.08 |
| 20-Day Moving Average | 7.50 |
| 10-Day Moving Average | 7.15 |
| Average True Range | 0.75 |
| RSI (14) | 51.46 |
| ADX | 31.88 |
| +DI | 20.37 |
| -DI | 25.21 |
| Chandelier Exit (Long, 3 ATRs) | 6.09 |
| Chandelier Exit (Short, 3 ATRs) | 7.90 |
| Upper Bollinger Bands | 8.78 |
| Lower Bollinger Band | 6.23 |
| Percent B (%b) | 0.35 |
| BandWidth | 33.97 |
| MACD Line | 0.30 |
| MACD Signal Line | 0.38 |
| MACD Histogram | -0.0761 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.07 | ||||
| Resistance 3 (R3) | 9.19 | 8.65 | 8.75 | ||
| Resistance 2 (R2) | 8.65 | 8.16 | 8.60 | 8.64 | |
| Resistance 1 (R1) | 7.89 | 7.85 | 7.62 | 7.77 | 8.53 |
| Pivot Point | 7.35 | 7.35 | 7.22 | 7.30 | 7.35 |
| Support 1 (S1) | 6.59 | 6.86 | 6.32 | 6.47 | 5.71 |
| Support 2 (S2) | 6.05 | 6.55 | 6.00 | 5.60 | |
| Support 3 (S3) | 5.29 | 6.05 | 5.50 | ||
| Support 4 (S4) | 5.17 |
